Types segmentation classifies Toxicology Consulting Services by the nature of the deliverable: regulatory consulting, risk assessment, validation & method development, and training & education. Regulatory consulting, which comprises dossier preparation, compliance audits, and liaison with agencies such as FDA, EMA, and EPA, generates roughly 40 % of market revenue, reflecting the high‑value, recurring nature of compliance cycles across drug and chemical portfolios. Risk assessment services—including hazard identification, dose‑response modeling, and exposure scenario analysis—account for approximately 35 % of the market, driven by corporate demand for quantitative safety margins and insurance underwriting requirements. Validation & method development, covering analytical method qualification, GLP verification, and bio‑analytical assay validation, contributes near 15 % as laboratories standardize protocols to meet global quality standards. Training & education, which delivers workshops, e‑learning modules, and certification programs for toxicologists and safety officers, represents the remaining 10 % and is expanding as firms internalize expertise to reduce external consulting spend. Together, these type categories delineate the market taxonomy that underpins revenue allocation within the Toxicology Consulting Services sector.